| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 |
| filingDate |
2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24fd5b0cb7012295f5e938afe74d8911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da837ca5d802695397e3d4a54664646d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bfa117bd953bfacfbd3b9370ef24ff9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ef0a395b9a248a024853be56c846358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3105f3f6f35c94f687c8b3b4c5a873d8 |
| publicationDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10208041-B2 |
| titleOfInvention |
Diazabicyclooctane compounds |
| abstract |
The present invention relates to compounds according to Formula (II): n nor a stereoisomer, tautomer or pharmaceutically acceptable salt or ester thereof, wherein A, R 1 and R 2 are defined herein. Also described are pharmaceutically acceptable compositions of Formula (II) compounds as well as methods for utilizing the compounds of Formula (II) and the pharmaceutically acceptable compositions of Formula (II) compounds as antibacterial agents and β-lactamase inhibitors, useful in the treatment of infectious diseases. |
| priorityDate |
2016-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |